Nori Appointed to Cornell Department of Radiation Oncology

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 3
Volume 5
Issue 3

FLUSHING, NY--The New York Hospital-Cornell Medical Center has appointed Dattatreyudu Nori, MD, a pioneer in the subspecialty of brachytherapy, to the position of professor and chairman of the Department of Radiation Oncology.

FLUSHING, NY--The New York Hospital-Cornell Medical Center hasappointed Dattatreyudu Nori, MD, a pioneer in the subspecialtyof brachytherapy, to the position of professor and chairman ofthe Department of Radiation Oncology.

Dr. Nori will remain as professor and chairman of the Departmentof Radiation Oncology and director of Oncology at The New YorkHospital Medical Center of Queens, which is affiliated with theNew York Hospital-Cornell Medical Center and is a member of theNew York Hospital Care Network.

In his new position, Dr. Nori will direct the department's clinicalactivities, its research program, and the training of residentphysicians in radiation oncology.

He will also oversee the administration of the radiation oncologyprograms for the New York Hospital Care Network's 13 member hospitals.The combined network program will be one of the largest in thecountry, providing state-of-the-art radiation treatments to morethan 3,000 new patients each year.

Recent Videos
Endobronchial ultrasound, robotic bronchoscopy, or other expensive procedures may exacerbate financial toxicity for patients seeking lung cancer care.
Destigmatizing cancer care for incarcerated patients may help ensure that they feel supported both in their treatment and their humanity.
Patients with mediastinal lymph node involved-lung cancer may benefit from chemoimmunotherapy in the neoadjuvant setting.
2 experts are featured in this series.
Advancements in antibody drug conjugates, bispecific therapies, and other targeted agents may hold promise in lung cancer management.
A lower percentage of patients who were released within 1 year of incarceration received guideline-concurrent care vs incarcerated patients.
Stressing the importance of prompt AE disclosure before they become severe can ensure that a patient can still undergo resection with curative intent.
A collaboration between the Connecticut Departments of Health and Corrections and the COPPER Center aimed to improve outcomes among incarcerated patients.
Thomas Marron, MD, PhD, presented a session on clinical data that established standards of care for stage II and III lung cancer treatment at CFS 2025.
Related Content